NO992980L - Nitroimidazol gelpreparat - Google Patents

Nitroimidazol gelpreparat

Info

Publication number
NO992980L
NO992980L NO992980A NO992980A NO992980L NO 992980 L NO992980 L NO 992980L NO 992980 A NO992980 A NO 992980A NO 992980 A NO992980 A NO 992980A NO 992980 L NO992980 L NO 992980L
Authority
NO
Norway
Prior art keywords
nitroimidazole
gel preparation
water
skin
bydroxyalkyl
Prior art date
Application number
NO992980A
Other languages
English (en)
Other versions
NO992980D0 (no
Inventor
Michael Goodman
Ke Lindahl
Original Assignee
Bioglan Ireland R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10804765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992980(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioglan Ireland R & D Ltd filed Critical Bioglan Ireland R & D Ltd
Publication of NO992980D0 publication Critical patent/NO992980D0/no
Publication of NO992980L publication Critical patent/NO992980L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Colloid Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Viskøst hydrogelpreparat for anvendelse ved topisk behandling av en hudlidelse som involverer tørr eller betent hud, om- fattende et antitnikrobielt aktivt nitroimidazolmedikament, et vann-blandbart alkylenglykol, et hydroksyalkylcellulose-gel- dannende middel og vann, bufret til å ha en fysiologisk akseptabel pH, og en fremgangsmåte for fremstilling av dette.
NO992980A 1996-12-20 1999-06-17 Nitroimidazol gelpreparat NO992980L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9626513.7A GB9626513D0 (en) 1996-12-20 1996-12-20 A pharmaceutical composition
PCT/GB1997/003512 WO1998027960A2 (en) 1996-12-20 1997-12-19 A nitroimidazole gel composition

Publications (2)

Publication Number Publication Date
NO992980D0 NO992980D0 (no) 1999-06-17
NO992980L true NO992980L (no) 1999-08-16

Family

ID=10804765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992980A NO992980L (no) 1996-12-20 1999-06-17 Nitroimidazol gelpreparat

Country Status (17)

Country Link
US (1) US6348203B1 (no)
EP (1) EP0946143B1 (no)
JP (1) JP2001507018A (no)
KR (1) KR20000069606A (no)
AT (1) ATE323466T1 (no)
AU (1) AU730812B2 (no)
CA (1) CA2275429A1 (no)
DE (1) DE69736998T2 (no)
DK (1) DK0946143T3 (no)
ES (1) ES2263183T3 (no)
GB (1) GB9626513D0 (no)
IE (1) IES80590B2 (no)
NO (1) NO992980L (no)
NZ (1) NZ336258A (no)
PT (1) PT946143E (no)
WO (1) WO1998027960A2 (no)
ZA (1) ZA9711455B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
DE60037892T2 (de) * 1999-07-16 2009-01-15 Shoei Co., Ltd. Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
JP2002212073A (ja) * 2001-01-15 2002-07-31 Shoei:Kk 水性液剤
SE0103528D0 (sv) 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
SE0301862D0 (sv) * 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
US7456207B2 (en) * 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
FR2866568B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter un desordre de la vascularisation cutanee
FR2866569B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
US8258164B2 (en) * 2006-09-12 2012-09-04 Curatek Pharmaceuticals Holding, Inc. Nitroimidazole composition and method
JP5238295B2 (ja) * 2007-03-09 2013-07-17 第一三共ヘルスケア株式会社 低刺激性透明半固形外用剤
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
DE102008006394A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
US8795727B2 (en) 2009-11-09 2014-08-05 Spotlight Technology Partners Llc Fragmented hydrogels
JP5881698B2 (ja) * 2010-07-19 2016-03-09 ブラセルズ ベンチャーズ コーポレーションＢｒｕｓｅｌｌｓ Ｖｅｎｔｕｒｅｓ Ｃｏｒｐ． エーテルヒドロキシエチルセルロースを含む抗微生物医療用ジェル
JP5954928B2 (ja) * 2010-11-19 2016-07-20 大同化成工業株式会社 皮膚潰瘍処置用外用剤のゲル状基剤
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN103763925A (zh) 2011-06-28 2014-04-30 梅迪奇制药有限公司 高剂量粘膜粘附甲硝唑水基凝胶制剂及其治疗细菌性阴道病的用途
US20140206735A1 (en) * 2012-12-20 2014-07-24 Medicis Pharmaceutical Corporation High dosage topical metronidazole aqueous-based gel formulations and their use to treat rosacea
US9446024B2 (en) 2013-06-25 2016-09-20 UNIVERSITé LAVAL Formulations for the treatment of vaginal disorders
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
AU2016344349B2 (en) * 2015-10-25 2022-05-19 Iview Therapeutics, Inc. Pharmaceutical formulations that form gel in situ
TWI814219B (zh) 2016-05-16 2023-09-01 美商因塔希亞治療公司 升糖素受體選擇性多肽和彼之使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421443C2 (de) * 1984-06-08 1996-09-05 Daicel Chem Stabile Gelmasse und Verfahren zu ihrer Herstellung
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
CA2011423A1 (en) * 1989-03-07 1990-09-07 Peter M. Taylor Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
GB2229443A (en) * 1989-03-07 1990-09-26 American Cyanamid Co Wound dressings
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
DK0564586T3 (da) * 1990-12-21 2002-07-15 Felice Bombart Vandige vaginaludskylninger og beslægtede fremgangsmåder
GB9105995D0 (en) * 1991-03-21 1991-05-08 Smith & Nephew Wound dressing
US5662924A (en) * 1991-03-21 1997-09-02 Smith & Nephew Plc Wound dressing
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution

Also Published As

Publication number Publication date
DE69736998T2 (de) 2007-03-01
CA2275429A1 (en) 1998-07-02
NZ336258A (en) 2001-04-27
JP2001507018A (ja) 2001-05-29
IES970906A2 (en) 1998-10-07
AU5330898A (en) 1998-07-17
PT946143E (pt) 2006-08-31
DK0946143T3 (da) 2006-08-21
KR20000069606A (ko) 2000-11-25
DE69736998D1 (de) 2007-01-04
EP0946143B1 (en) 2006-04-19
ATE323466T1 (de) 2006-05-15
ZA9711455B (en) 1998-09-02
GB9626513D0 (en) 1997-02-05
ES2263183T3 (es) 2006-12-01
US6348203B1 (en) 2002-02-19
IES80590B2 (en) 1998-10-07
WO1998027960A2 (en) 1998-07-02
AU730812B2 (en) 2001-03-15
NO992980D0 (no) 1999-06-17
WO1998027960A3 (en) 1998-09-11
EP0946143A2 (en) 1999-10-06

Similar Documents

Publication Publication Date Title
NO992980L (no) Nitroimidazol gelpreparat
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
ATE274900T1 (de) Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels
DE69617723D1 (de) Wachsumsfaktoren enthaltende gelformulierungen
KR920700705A (ko) 상처용 겔 조성물 및 이것의 사용방법
MA22677A1 (fr) Compositions cosmetiques en gels
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
BR0008787A (pt) Sistema à base de colágeno injetável para aplicação de células ou agentes terapêuticos
EP0640647A3 (en) Ion-crosslinked glycosaminoglycan gels to increase soft tissue and for drug delivery.
AU2002342765A1 (en) Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
FR2542616B1 (fr) Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
ATE240094T1 (de) Ophthalmische zusammensetzungen in form wässriger gele
ES2176495T3 (es) Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida.
BR9903751A (pt) Composição para uso cosmético e/ou dermatológico, utilização cosmética da composição, utilização da composição e utilização de pelo menos um ácido aminossulfÈnico n-substituìdo
SE9403905D0 (sv) New formulations
FR2719475B1 (fr) Composition cosmétique et/ou dermatologique à gélifiant polymérique cationique, ses utilisations notamment pour la dépigmentation de la peau.
PT1140001E (pt) Composicao para tratamento de queimaduras
AR017170A1 (es) Composicion oftalmologica
IT9048186A0 (it) Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti
TH9143A (th) ส่วนประกอบของเจบทาแผลและวิธีการใช้
GT199600070A (es) Composicion de gel cosmetica teniendo irritacion de la piel reducida.
TH9143EX (th) ส่วนประกอบของเจบทาแผลและวิธีการใช้

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application